APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Abortus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Brucella Abortus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchBrucella Abortus Vaccine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Abortus Vaccine Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Brucella Abortus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Abortus Vaccine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Abortus Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Brucella Abortus Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Brucella Abortus Vaccine include Zoetis, Qilu Animal Health, Merck Animal Health, Vetal, VECOL, Tecnovax, SYVA Laboratorios, Onderstepoort Biological Products and Merial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Brucella Abortus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brucella Abortus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brucella Abortus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brucella Abortus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Brucella Abortus Vaccine Segment by Company

Zoetis

Qilu Animal Health

Merck Animal Health

Vetal

VECOL

Tecnovax

SYVA Laboratorios

Onderstepoort Biological Products

Merial

JOVAC

Instituto Rosenbusch

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals

Hester Biosciences

Dollvet

CZ Veterinaria

Colorado Serum Company

CEVA

Centro Diagnostico Veterinario

CAVAC

Biovet

Biogenesis Bago

Brucella Abortus Vaccine Segment by Type

Vector Vaccines

Subunit Vaccines

DNA Vaccines

B. Abortus Recombinant Mutants

Others

Brucella Abortus Vaccine Segment by Application

Pigs

Sheep

Cattles

Others

Brucella Abortus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Abortus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Abortus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Abortus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brucella Abortus Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Brucella Abortus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Brucella Abortus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Brucella Abortus Vaccine Industry Trends Table 2. Brucella Abortus Vaccine Industry Drivers Table 3. Brucella Abortus Vaccine Industry Opportunities and Challenges Table 4. Brucella Abortus Vaccine Industry Restraints Table 5. Global Brucella Abortus Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Brucella Abortus Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Brucella Abortus Vaccine Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Brucella Abortus Vaccine Sales Market Share by Manufacturers Table 9. Global Brucella Abortus Vaccine Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Brucella Abortus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Brucella Abortus Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Brucella Abortus Vaccine Manufacturers, Product Type & Application Table 13. Global Brucella Abortus Vaccine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Brucella Abortus Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vector Vaccines Table 17. Major Manufacturers of Subunit Vaccines Table 18. Major Manufacturers of DNA Vaccines Table 19. Major Manufacturers of B. Abortus Recombinant Mutants Table 20. Major Manufacturers of Others Table 21. Global Brucella Abortus Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Brucella Abortus Vaccine Sales by Type (2021-2026) & (k units) Table 23. Global Brucella Abortus Vaccine Sales by Type (2027-2032) & (k units) Table 24. Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2026) Table 25. Global Brucella Abortus Vaccine Sales Market Share by Type (2027-2032) Table 26. Global Brucella Abortus Vaccine Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Brucella Abortus Vaccine Revenue by Type (2021-2026) & (k units) Table 28. Global Brucella Abortus Vaccine Revenue by Type (2027-2032) & (k units) Table 29. Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2026) Table 30. Global Brucella Abortus Vaccine Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Pigs Table 32. Major Manufacturers of Sheep Table 33. Major Manufacturers of Cattles Table 34. Major Manufacturers of Others Table 35. Global Brucella Abortus Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Brucella Abortus Vaccine Sales by Application (2021-2026) & (k units) Table 37. Global Brucella Abortus Vaccine Sales by Application (2027-2032) & (k units) Table 38. Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2026) Table 39. Global Brucella Abortus Vaccine Sales Market Share by Application (2027-2032) Table 40. Global Brucella Abortus Vaccine Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Brucella Abortus Vaccine Revenue by Application (2021-2026) & (k units) Table 42. Global Brucella Abortus Vaccine Revenue by Application (2027-2032) & (k units) Table 43. Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2026) Table 44. Global Brucella Abortus Vaccine Revenue Market Share by Application (2027-2032) Table 45. Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Brucella Abortus Vaccine Sales by Region (2021-2026) & (k units) Table 47. Global Brucella Abortus Vaccine Sales Market Share by Region (2021-2026) Table 48. Global Brucella Abortus Vaccine Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Brucella Abortus Vaccine Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 52. North America Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 53. Europe Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 55. Europe Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 62. Global Brucella Abortus Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Brucella Abortus Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Brucella Abortus Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Brucella Abortus Vaccine Revenue Market Share by Region (2021-2026) Table 66. Global Brucella Abortus Vaccine Revenue Market Share by Region (2027-2032) Table 67. Zoetis Company Information Table 68. Zoetis Business Overview Table 69. Zoetis Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Zoetis Brucella Abortus Vaccine Product Portfolio Table 71. Zoetis Recent Development Table 72. Qilu Animal Health Company Information Table 73. Qilu Animal Health Business Overview Table 74. Qilu Animal Health Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Qilu Animal Health Brucella Abortus Vaccine Product Portfolio Table 76. Qilu Animal Health Recent Development Table 77. Merck Animal Health Company Information Table 78. Merck Animal Health Business Overview Table 79. Merck Animal Health Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Merck Animal Health Brucella Abortus Vaccine Product Portfolio Table 81. Merck Animal Health Recent Development Table 82. Vetal Company Information Table 83. Vetal Business Overview Table 84. Vetal Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Vetal Brucella Abortus Vaccine Product Portfolio Table 86. Vetal Recent Development Table 87. VECOL Company Information Table 88. VECOL Business Overview Table 89. VECOL Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. VECOL Brucella Abortus Vaccine Product Portfolio Table 91. VECOL Recent Development Table 92. Tecnovax Company Information Table 93. Tecnovax Business Overview Table 94. Tecnovax Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Tecnovax Brucella Abortus Vaccine Product Portfolio Table 96. Tecnovax Recent Development Table 97. SYVA Laboratorios Company Information Table 98. SYVA Laboratorios Business Overview Table 99. SYVA Laboratorios Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio Table 101. SYVA Laboratorios Recent Development Table 102. Onderstepoort Biological Products Company Information Table 103. Onderstepoort Biological Products Business Overview Table 104. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio Table 106. Onderstepoort Biological Products Recent Development Table 107. Merial Company Information Table 108. Merial Business Overview Table 109. Merial Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Merial Brucella Abortus Vaccine Product Portfolio Table 111. Merial Recent Development Table 112. JOVAC Company Information Table 113. JOVAC Business Overview Table 114. JOVAC Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. JOVAC Brucella Abortus Vaccine Product Portfolio Table 116. JOVAC Recent Development Table 117. Instituto Rosenbusch Company Information Table 118. Instituto Rosenbusch Business Overview Table 119. Instituto Rosenbusch Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio Table 121. Instituto Rosenbusch Recent Development Table 122. Institute of Animal Health and Veterinary Biologicals Company Information Table 123. Institute of Animal Health and Veterinary Biologicals Business Overview Table 124. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio Table 126. Institute of Animal Health and Veterinary Biologicals Recent Development Table 127. Indian Immunologicals Company Information Table 128. Indian Immunologicals Business Overview Table 129. Indian Immunologicals Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Indian Immunologicals Brucella Abortus Vaccine Product Portfolio Table 131. Indian Immunologicals Recent Development Table 132. Hester Biosciences Company Information Table 133. Hester Biosciences Business Overview Table 134. Hester Biosciences Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Hester Biosciences Brucella Abortus Vaccine Product Portfolio Table 136. Hester Biosciences Recent Development Table 137. Dollvet Company Information Table 138. Dollvet Business Overview Table 139. Dollvet Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Dollvet Brucella Abortus Vaccine Product Portfolio Table 141. Dollvet Recent Development Table 142. CZ Veterinaria Company Information Table 143. CZ Veterinaria Business Overview Table 144. CZ Veterinaria Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. CZ Veterinaria Brucella Abortus Vaccine Product Portfolio Table 146. CZ Veterinaria Recent Development Table 147. Colorado Serum Company Company Information Table 148. Colorado Serum Company Business Overview Table 149. Colorado Serum Company Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Colorado Serum Company Brucella Abortus Vaccine Product Portfolio Table 151. Colorado Serum Company Recent Development Table 152. CEVA Company Information Table 153. CEVA Business Overview Table 154. CEVA Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. CEVA Brucella Abortus Vaccine Product Portfolio Table 156. CEVA Recent Development Table 157. Centro Diagnostico Veterinario Company Information Table 158. Centro Diagnostico Veterinario Business Overview Table 159. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio Table 161. Centro Diagnostico Veterinario Recent Development Table 162. CAVAC Company Information Table 163. CAVAC Business Overview Table 164. CAVAC Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 165. CAVAC Brucella Abortus Vaccine Product Portfolio Table 166. CAVAC Recent Development Table 167. Biovet Company Information Table 168. Biovet Business Overview Table 169. Biovet Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 170. Biovet Brucella Abortus Vaccine Product Portfolio Table 171. Biovet Recent Development Table 172. Biogenesis Bago Company Information Table 173. Biogenesis Bago Business Overview Table 174. Biogenesis Bago Brucella Abortus Vaccine Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 175. Biogenesis Bago Brucella Abortus Vaccine Product Portfolio Table 176. Biogenesis Bago Recent Development Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Brucella Abortus Vaccine Distributors List Table 180. Brucella Abortus Vaccine Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Brucella Abortus Vaccine Product Image Figure 2. Global Brucella Abortus Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Abortus Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Brucella Abortus Vaccine Sales (2021-2032) & (k units) Figure 5. Global Brucella Abortus Vaccine Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Brucella Abortus Vaccine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vector Vaccines Image Figure 9. Subunit Vaccines Image Figure 10. DNA Vaccines Image Figure 11. B. Abortus Recombinant Mutants Image Figure 12. Others Image Figure 13. Global Brucella Abortus Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Brucella Abortus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2032) Figure 16. Global Brucella Abortus Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Brucella Abortus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2032) Figure 19. Pigs Image Figure 20. Sheep Image Figure 21. Cattles Image Figure 22. Others Image Figure 23. Global Brucella Abortus Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Brucella Abortus Vaccine Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2032) Figure 26. Global Brucella Abortus Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Brucella Abortus Vaccine Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2032) Figure 29. North America Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 31. U.S. Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 36. Germany Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 43. China Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Brucella Abortus Vaccine Sales Market Share by Country (2021-2032) Figure 51. Brazil Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Brucella Abortus Vaccine Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Brucella Abortus Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Brucella Abortus Vaccine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Figure 62. North America Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Figure 64. Europe Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Brucella Abortus Vaccine Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Brucella Abortus Vaccine Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Brucella Abortus Vaccine Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Vector Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • B. Abortus Recombinant Mutants
  • Others
Applications
  • Pigs
  • Sheep
  • Cattles
  • Others
Companies covered
  • Zoetis
  • Qilu Animal Health
  • Merck Animal Health
  • Vetal
  • VECOL
  • Tecnovax
  • SYVA Laboratorios
  • Onderstepoort Biological Products
  • Merial
  • JOVAC
  • Instituto Rosenbusch
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals
  • Hester Biosciences
  • Dollvet
  • CZ Veterinaria
  • Colorado Serum Company
  • CEVA
  • Centro Diagnostico Veterinario
  • CAVAC
  • Biovet
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brucella Abortus Vaccine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brucella Abortus Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Brucella Abortus Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Brucella Abortus Vaccine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Brucella Abortus Vaccine Market Dynamics
  1. 2.1 Brucella Abortus Vaccine Industry Trends
  2. 2.2 Brucella Abortus Vaccine Industry Drivers
  3. 2.3 Brucella Abortus Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Abortus Vaccine Industry Restraints
3 Brucella Abortus Vaccine Market by Manufacturers
  1. 3.1 Global Brucella Abortus Vaccine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Brucella Abortus Vaccine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Brucella Abortus Vaccine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Brucella Abortus Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Brucella Abortus Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Brucella Abortus Vaccine Manufacturers, Product Type & Application
  7. 3.7 Global Brucella Abortus Vaccine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Brucella Abortus Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Brucella Abortus Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Brucella Abortus Vaccine Tier 1, Tier 2, and Tier 3
4 Brucella Abortus Vaccine Market by Type
  1. 4.1 Brucella Abortus Vaccine Type Introduction
  2. 4.1.1 Vector Vaccines
  3. 4.1.2 Subunit Vaccines
  4. 4.1.3 DNA Vaccines
  5. 4.1.4 B. Abortus Recombinant Mutants
  6. 4.1.5 Others
  7. 4.2 Global Brucella Abortus Vaccine Sales by Type
  8. 4.2.1 Global Brucella Abortus Vaccine Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Brucella Abortus Vaccine Sales by Type (2021-2032)
  10. 4.2.3 Global Brucella Abortus Vaccine Sales Market Share by Type (2021-2032)
  11. 4.3 Global Brucella Abortus Vaccine Revenue by Type
  12. 4.3.1 Global Brucella Abortus Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Brucella Abortus Vaccine Revenue by Type (2021-2032)
  14. 4.3.3 Global Brucella Abortus Vaccine Revenue Market Share by Type (2021-2032)
5 Brucella Abortus Vaccine Market by Application
  1. 5.1 Brucella Abortus Vaccine Application Introduction
  2. 5.1.1 Pigs
  3. 5.1.2 Sheep
  4. 5.1.3 Cattles
  5. 5.1.4 Others
  6. 5.2 Global Brucella Abortus Vaccine Sales by Application
  7. 5.2.1 Global Brucella Abortus Vaccine Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Brucella Abortus Vaccine Sales by Application (2021-2032)
  9. 5.2.3 Global Brucella Abortus Vaccine Sales Market Share by Application (2021-2032)
  10. 5.3 Global Brucella Abortus Vaccine Revenue by Application
  11. 5.3.1 Global Brucella Abortus Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Brucella Abortus Vaccine Revenue by Application (2021-2032)
  13. 5.3.3 Global Brucella Abortus Vaccine Revenue Market Share by Application (2021-2032)
6 Global Brucella Abortus Vaccine Sales by Region
  1. 6.1 Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brucella Abortus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Brucella Abortus Vaccine Sales by Region (2021-2026)
  4. 6.2.2 Global Brucella Abortus Vaccine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Brucella Abortus Vaccine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Brucella Abortus Vaccine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Brucella Abortus Vaccine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Brucella Abortus Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Brucella Abortus Vaccine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Brucella Abortus Vaccine Revenue by Region
  1. 7.1 Global Brucella Abortus Vaccine Revenue by Region
  2. 7.1.1 Global Brucella Abortus Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Brucella Abortus Vaccine Revenue by Region (2021-2026)
  4. 7.1.3 Global Brucella Abortus Vaccine Revenue by Region (2027-2032)
  5. 7.1.4 Global Brucella Abortus Vaccine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Brucella Abortus Vaccine Revenue (2021-2032)
  8. 7.2.2 North America Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Brucella Abortus Vaccine Revenue (2021-2032)
  11. 7.3.2 Europe Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Brucella Abortus Vaccine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Brucella Abortus Vaccine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Brucella Abortus Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Qilu Animal Health
  8. 8.2.1 Qilu Animal Health Company Information
  9. 8.2.2 Qilu Animal Health Business Overview
  10. 8.2.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
  12. 8.2.5 Qilu Animal Health Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Vetal
  20. 8.4.1 Vetal Company Information
  21. 8.4.2 Vetal Business Overview
  22. 8.4.3 Vetal Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Vetal Brucella Abortus Vaccine Product Portfolio
  24. 8.4.5 Vetal Recent Developments
  25. 8.5 VECOL
  26. 8.5.1 VECOL Company Information
  27. 8.5.2 VECOL Business Overview
  28. 8.5.3 VECOL Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 VECOL Brucella Abortus Vaccine Product Portfolio
  30. 8.5.5 VECOL Recent Developments
  31. 8.6 Tecnovax
  32. 8.6.1 Tecnovax Company Information
  33. 8.6.2 Tecnovax Business Overview
  34. 8.6.3 Tecnovax Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
  36. 8.6.5 Tecnovax Recent Developments
  37. 8.7 SYVA Laboratorios
  38. 8.7.1 SYVA Laboratorios Company Information
  39. 8.7.2 SYVA Laboratorios Business Overview
  40. 8.7.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
  42. 8.7.5 SYVA Laboratorios Recent Developments
  43. 8.8 Onderstepoort Biological Products
  44. 8.8.1 Onderstepoort Biological Products Company Information
  45. 8.8.2 Onderstepoort Biological Products Business Overview
  46. 8.8.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
  48. 8.8.5 Onderstepoort Biological Products Recent Developments
  49. 8.9 Merial
  50. 8.9.1 Merial Company Information
  51. 8.9.2 Merial Business Overview
  52. 8.9.3 Merial Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merial Brucella Abortus Vaccine Product Portfolio
  54. 8.9.5 Merial Recent Developments
  55. 8.10 JOVAC
  56. 8.10.1 JOVAC Company Information
  57. 8.10.2 JOVAC Business Overview
  58. 8.10.3 JOVAC Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 JOVAC Brucella Abortus Vaccine Product Portfolio
  60. 8.10.5 JOVAC Recent Developments
  61. 8.11 Instituto Rosenbusch
  62. 8.11.1 Instituto Rosenbusch Company Information
  63. 8.11.2 Instituto Rosenbusch Business Overview
  64. 8.11.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
  66. 8.11.5 Instituto Rosenbusch Recent Developments
  67. 8.12 Institute of Animal Health and Veterinary Biologicals
  68. 8.12.1 Institute of Animal Health and Veterinary Biologicals Company Information
  69. 8.12.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  70. 8.12.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
  72. 8.12.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  73. 8.13 Indian Immunologicals
  74. 8.13.1 Indian Immunologicals Company Information
  75. 8.13.2 Indian Immunologicals Business Overview
  76. 8.13.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
  78. 8.13.5 Indian Immunologicals Recent Developments
  79. 8.14 Hester Biosciences
  80. 8.14.1 Hester Biosciences Company Information
  81. 8.14.2 Hester Biosciences Business Overview
  82. 8.14.3 Hester Biosciences Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
  84. 8.14.5 Hester Biosciences Recent Developments
  85. 8.15 Dollvet
  86. 8.15.1 Dollvet Company Information
  87. 8.15.2 Dollvet Business Overview
  88. 8.15.3 Dollvet Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dollvet Brucella Abortus Vaccine Product Portfolio
  90. 8.15.5 Dollvet Recent Developments
  91. 8.16 CZ Veterinaria
  92. 8.16.1 CZ Veterinaria Company Information
  93. 8.16.2 CZ Veterinaria Business Overview
  94. 8.16.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
  96. 8.16.5 CZ Veterinaria Recent Developments
  97. 8.17 Colorado Serum Company
  98. 8.17.1 Colorado Serum Company Company Information
  99. 8.17.2 Colorado Serum Company Business Overview
  100. 8.17.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
  102. 8.17.5 Colorado Serum Company Recent Developments
  103. 8.18 CEVA
  104. 8.18.1 CEVA Company Information
  105. 8.18.2 CEVA Business Overview
  106. 8.18.3 CEVA Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 CEVA Brucella Abortus Vaccine Product Portfolio
  108. 8.18.5 CEVA Recent Developments
  109. 8.19 Centro Diagnostico Veterinario
  110. 8.19.1 Centro Diagnostico Veterinario Company Information
  111. 8.19.2 Centro Diagnostico Veterinario Business Overview
  112. 8.19.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
  114. 8.19.5 Centro Diagnostico Veterinario Recent Developments
  115. 8.20 CAVAC
  116. 8.20.1 CAVAC Company Information
  117. 8.20.2 CAVAC Business Overview
  118. 8.20.3 CAVAC Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 CAVAC Brucella Abortus Vaccine Product Portfolio
  120. 8.20.5 CAVAC Recent Developments
  121. 8.21 Biovet
  122. 8.21.1 Biovet Company Information
  123. 8.21.2 Biovet Business Overview
  124. 8.21.3 Biovet Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Biovet Brucella Abortus Vaccine Product Portfolio
  126. 8.21.5 Biovet Recent Developments
  127. 8.22 Biogenesis Bago
  128. 8.22.1 Biogenesis Bago Company Information
  129. 8.22.2 Biogenesis Bago Business Overview
  130. 8.22.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
  132. 8.22.5 Biogenesis Bago Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brucella Abortus Vaccine Value Chain Analysis
  2. 9.1.1 Brucella Abortus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brucella Abortus Vaccine Production Mode & Process
  6. 9.2 Brucella Abortus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brucella Abortus Vaccine Distributors
  9. 9.2.3 Brucella Abortus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst